Yuan, Wenyi
Liu, Mian
Yang, Dapeng
Shi, Yirui
Wang, Zhikang
Cao, Xuan
Liang, Jun
Geng, Linyu
Zhang, Huayong
Feng, Xuebing
Jin, Ziyi
Wang, Dandan
Sun, Lingyun
Funding for this research was provided by:
Nanjing Drum Tower Hospital (2022-YXZX-MY-03)
Jiangsu Provincial Key Research and Development Program (H2023087)
Innovative Research Group Project of the National Natural Science Foundation of China (82330055)
Natural Science Foundation of Jiangsu Province (BK20231119)
Article History
Received: 15 October 2024
Accepted: 17 February 2025
First Online: 9 March 2025
Declarations
:
: (1) Title of the approved project: Clinical study of umbilical cord mesenchymal stem cell transplantation in the treatment of autoimmune diseases; (2) Name of the institutional approval committee or unit: Nanjing Drum Tower Hospital Affiliated to Nanjing University School of Medicine; (3) Approval number: 2009004; (4) Date of approval: January 9, 2009. Because this study is a retrospective study, it is approved by the ethics committee and does not require informed consent.
: Not applicable.
: The authors confirm that the research project was not conducted under any circumstances where they had a potential commercial or financial conflict of interest.